The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management […]
Recent Content
- Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study
- (no title)
- Darzalex Faspro is first FDA-approved therapy for high-risk smoldering multiple myeloma
- Darzalex Faspro is first FDA-approved therapy for high-risk smoldering multiple myeloma
- FDA speeds development of oral pancreatic cancer treatment
- (no title)
- (no title)
- Oral safusidenib begins trial as maintenance for high-grade glioma
- Outcomes of relapse after teclistamab therapy in multiple myeloma
- Canada agency backs coverage of new ovarian cancer drug